This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
We have completed recruitment for the ‘RESOLVE trial for chronic low back pain’, a commonwealth government funded randomised controlled trial in which we are investigating the effectiveness of new treatment …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Closed: follow-up continuing
Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes …
CONDITION: Oral and Gastrointestinal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke. …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 50 years
TRIAL STATUS: Closed: follow-up continuing
Genital Psoriasis If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
If you answered yes to these questions, you may be able to take part in a new research study. Our Research Centre in Drummoyne is participating in the study. …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing